| Literature DB >> 1362221 |
M A Crocq1, R Mant, P Asherson, J Williams, Y Hode, A Mayerova, D Collier, L Lannfelt, P Sokoloff, J C Schwartz.
Abstract
Disturbances in dopamine neurotransmission have been postulated to underlie schizophrenia. We report data from two independent studies of a BalI polymorphism in the dopamine D3 receptor gene in patients with schizophrenia. In both studies, more patients than controls were homozygous (p = 0.005, p = 0.008). When pooled data were analysed, this difference was highly significant (p = 0.0001) with a relative risk of schizophrenia in homozygotes of 2.61 (95% confidence intervals 1.60-4.26).Entities:
Mesh:
Substances:
Year: 1992 PMID: 1362221 PMCID: PMC1016201 DOI: 10.1136/jmg.29.12.858
Source DB: PubMed Journal: J Med Genet ISSN: 0022-2593 Impact factor: 6.318